Article info
Commentary
Epigenetic modulation of immunity: towards new therapeutic avenues in hepatocellular carcinoma?
- Correspondence to Dr Angelique Gougelet, UMRS1138-Team 24, Centre de Recherche des Cordeliers, Paris 75006, France; angelique.gougelet{at}inserm.fr
Citation
Epigenetic modulation of immunity: towards new therapeutic avenues in hepatocellular carcinoma?
Publication history
- Received May 31, 2019
- Revised June 3, 2019
- Accepted June 6, 2019
- First published June 26, 2019.
Online issue publication
September 06, 2019
Article Versions
- Previous version (26 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.